Evidence map›Paper›PMID 33922170›Full record

ReviewNanomaterials (Basel, Switzerland)2021

Applications and Biological Activity of Nanoparticles of Manganese and Manganese Oxides in In Vitro and In Vivo Models.

Zuzanna Sobańska, Joanna Roszak, Kornelia Kowalczyk, Maciej Stępnik

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. MnAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Nanoengineered γ MnOLife (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Zuzanna SobańskaDepartment of Translational Research, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland.ORCID 0000-0002-1580-092X
Joanna RoszakDepartment of Translational Research, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland.ORCID 0000-0002-0739-9443
Kornelia KowalczykDepartment of Translational Research, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland.
Maciej StępnikDepartment of Translational Research, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland.ORCID 0000-0003-1586-2482
Nofer Institute of Occupational Medicine · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expanding applications of nanotechnology seem to be a response to many technological, environmental, and medical challenges. The unique properties of nanoparticles allow for developing new technologies and therapies. Among many investigated compounds is manganese and its oxides, which in the form of nanoparticles, could be a promising alternative for gadolinium-based contrast agents used in diagnostic imaging. Manganese, which is essential for living organisms as an enzyme cofactor, under excessive exposure-for example, due to water contamination or as an occupational hazard for welders-can lead to neurological disorders, including manganism-a condition similar to Parkinson's disease. This review attempts to summarise the available literature data on the potential applications of manganese and manganese oxide nanoparticles and their biological activity. Some of the published studies, both in vitro and in vivo, show negative effects of exposure to manganese, mainly on the nervous system, whereas other data suggest that it is possible to develop functionalised nanoparticles with negligible toxicity and novel promising properties.

Indexed as

biological effectsin vitroin vivomanganese oxidesnanoparticles

Identifiers

PMID33922170
PMCPMC8145730
OpenAlexW3154607262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.